ASTEC: Automatic selection of clinical trials based on eligibility criteria

被引:1
|
作者
Cuggia, M. [1 ]
Dufour, J. -C. [2 ]
Zekri, O. [3 ]
Gibaud, I. [4 ]
Garde, C. [5 ]
Bohec, C. [6 ]
Duvauferrier, R. [1 ]
Fieschi, D. [2 ]
Besana, P. [1 ]
Charlois, L. [2 ]
Bourde, A. [1 ]
Garcelon, N. [1 ]
Laurent, J. [3 ]
Fieschi, M. [2 ]
Dameron, O. [1 ]
机构
[1] Univ Rennes 1, INSERM, UMR 936, F-35043 Rennes, France
[2] Univ Aix Marseille, LERTIM, F-13005 Aix Marseille, France
[3] CRLCC Ctr Eugene Marquis, Rennes, France
[4] SIB, Rennes, France
[5] ENOVACOM, Marseille, France
[6] Reseau Onco, F-35042 Bretagne, France
关键词
D O I
10.1016/j.irbm.2012.02.001
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Automatic Selection of clinical Trial based on Eligibility Criteria (ASTEC) project is to automate, so as to make it systematic, the search of cancer clinical trials, by reusing the patient data contained into an oncologic electronic health record. ASTEC project tackles two major scientific challenges for medical informatics: 1) the syntactic and semantic interoperability between information systems. The oncologic electronic medical records and the recruitment decision system must be interoperable. The ASTEC project proposes a framework of syntactico-semantic interoperability based on international standards. Generic methods of mediation and reasoning based on ontologies are developed to match data from the electronic medical records to the inclusion/exclusion criteria of clinical trials; 2) a decision support system for recruitment. We have developed inference methods on the electronic medical records adapted to the data structure as well as the eligibility criteria, this paper, we present and justify our choices, concerning the medical process in oncology and the scientific and technical aspects. Furthermore the system will be evaluated in real time. The aim is to demonstrate a significative improvement of the prescreening rate of patient. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码:150 / 164
页数:15
相关论文
共 50 条
  • [41] Eligibility criteria in haematological cancer clinical trials-what's needed?
    Calissano, Mattia
    Panico, Maria Beatrice
    O'Connor, Daniel J.
    LANCET HAEMATOLOGY, 2020, 7 (01): : E10 - E10
  • [42] Eligibility criteria perpetuate disparities in enrollment and participation in pancreatic cancer clinical trials
    Riner, Andrea N.
    Girma, Selamawit
    Skoro, Nevena
    Gal, Tamas S.
    Herremans, Kelly M.
    Mukhopadhyay, Nitai
    Vudatha, Vignesh
    Raman, Shreya
    George, Thomas
    Trevino, Jose G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [43] Eligibility Criteria Related to Hormone Therapy in Acne Clinical Trials: A Systematic Review
    DeGrazia, Taryn M.
    Rolader, Robin
    Thiboutot, Diane M.
    Yeung, Howa
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (01) : 189 - 191
  • [44] Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
    Kerstin Breithaupt-Groegler
    Christoph Coch
    Martin Coenen
    Frank Donath
    Katharina Erb-Zohar
    Klaus Francke
    Karin Goehler
    Mario Iovino
    Klaus Peter Kammerer
    Gerd Mikus
    Jens Rengelshausen
    Hildegard Sourgens
    Reinhard Schinzel
    Thomas Sudhop
    Georg Wensing
    European Journal of Clinical Pharmacology, 2017, 73 : 409 - 416
  • [45] Finding appropriate clinical trials: Evaluating encoded eligibility criteria with incomplete data
    Ash, N
    Ogunyemi, O
    Zeng, Q
    Ohno-Machado, L
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2001, : 27 - 31
  • [46] Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trials
    Breithaupt-Groegler, Kerstin
    Coch, Christoph
    Coenen, Martin
    Donath, Frank
    Erb-Zohar, Katharina
    Francke, Klaus
    Goehler, Karin
    Iovino, Mario
    Kammerer, Klaus Peter
    Mikus, Gerd
    Rengelshausen, Jens
    Sourgens, Hildegard
    Schinzel, Reinhard
    Sudhop, Thomas
    Wensing, Georg
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (04) : 409 - 416
  • [47] Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials
    Zhang, Sheng
    Liang, Fei
    Li, Wenfeng
    Tannock, Ian
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (11):
  • [48] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
    Mercier, Benjamin D.
    Govindarajan, Ameish
    Castro, Daniela V.
    Li, Xiaochen
    Philip, Errol J.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Chehrazi-Raffle, Alexander
    Ebrahimi, Hedyeh
    Rock, Adam
    Zengin, Zeynep Busra
    Meza, Luis A.
    Dizman, Nazli
    Hsu, Joann
    Liu, Sandy
    Dorff, Tanya B.
    Pal, Sumanta K.
    Tripathi, Abhishek
    CANCER MEDICINE, 2025, 14 (07):
  • [49] Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
    Outtier, An
    Janssens, Rosanne
    Barbier, Liese
    Sabino, Joao
    Verstockt, Bram
    Vermeire, Severine
    Huys, Isabelle
    Ferrante, Marc
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
  • [50] Eligibility criteria of randomized controlled trials - Reply
    Fowler, Robert A.
    Van Spall, Harriette G. C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (01): : 39 - 40